WHO researchers report H1N1 strain passing among people and proving immune to Tamiflu

KUALA LUMPUR, Jan 21 (Bernama) -- The cause of death of two babies at adaycare centre in Taman Permata here on Thursday has not been ascertained yet,Health director-general Datuk Seri Dr Hasan Abdul Rahman said. He said the ministry was unable to confirm at the moment whether bacterialinfection, as reported by the media, was the cause of death while thepossibility of milk aspiration could not be ...

CDC: Flu in Ohio facility killed 7 young people with neurologic disorders An influenza outbreak last year struck more than half of the residents in an Ohio facility for children and young adults with neurodevelopmental conditions and killed seven of them, pointing up the need for prompt testing and early antiviral treatment in such patients, the Centers for Disease Control and Prevention (CDC ...

NEW YORK (Reuters Health) - After billions of dollars worldwide have been spent stockpiling the anti-flu drug Tamiflu, two new reports cast doubt on the medication's benefits and say its side effects may have been underestimated. According to the widely respected Cochrane Collaboration, which analyzes past medical research, Tamiflu shortened the typical flu attack by just one day. And it didn't ...

Roche Holding AG’s Tamiflu antiviral treatment may not be as safe and effective as the Swiss drugmaker says, according to independent researchers who asked the company to publish data withheld from public review.

Roche Holding AG (ROG) ’s Tamiflu antiviral treatment may not be as safe and effective as the Swiss drugmaker says, according to independent researchers who asked the company to publish data withheld from public review.

CEL-SCI Corporation is in the process of expanding its Phase III clinical trial of the investigational therapy Multikine * to 4 additional European countries - Spain, Czech Republic, Slovakia and Croatia.

A masked girl sits with a classmate at a kindergarten in a residential estate in Hong Kong on Jun. 11, 2009.

Annual flu shots might soon become a thing of the past, and threats such as avian and swine flu might disappear with them as a vaccine touted as the "holy grail" of flu treatment could be ready for human trials next year.

Roche Holding AG’s Tamiflu antiviral treatment may not be as safe and effective as the Swiss drugmaker says, according to independent researchers who asked the company to publish data withheld from public review.